 |
 |
 |
 |
 |
 |
|
||||||||||||||
SELECT PUBLICATIONS
Athas WF et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000;92(3):269-71. Abstract
Dixon J et al. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective. Eur J Cancer 2002;38(17):2214-21. Abstract
Ellis M et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol 2001 Sep 15;19(18):3795-7. Abstract
Ellis M. Preoperative endocrine therapy for older women with breast cancer: renewed interest in an old idea. Cancer Control. 2000 Nov-Dec;7(6):557-62. Abstract
Murray J et al. Letrozole and Anastrozole: a pre-operative study of their effects on ER-positive breast cancers in postmenopausal women. San Antonio Breast Cancer Symposium 2004. No abstract available
Semiglazov V et al. The relative efficacy of neoadjuvant endocrine therapy vs chemotherapy in postmenopausal women with ER-positive breast cancer. ASCO 2004. Abstract 519
The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc announce positive study results demonstrating Oncotype DX genomic breast cancer assay predicts chemotherapy response. Press Release
Weed DW et al. Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy 2005;4(2):121-9. Abstract
| Table of Contents | Top of Page |
